Under new leadership, the United States Patent and Trademark Office has recently adjusted its approach to patentability of artificial intelligence technologies in multiple meaningful respects.
Continue Reading Recalibrating AI Patent Strategy: What the USPTO Shift Means — and What it Doesn’t
Patent examiners have had access to AI-driven prior art searching since late 2022, but its use is expanding and is now even required in some technology groups (art units). Chief Information Officer of the USPTO, Jamie Holcombe, touted 30% of references result from using SimSearch.
SimSearch, the AI-based Similarity Search tool available through the USPTO’s
The Federal Circuit’s recent decision in PowerBlock Holdings, Inc. v. iFit, Inc., No. 2024-1177 (Fed. Cir. Aug. 11, 2025), a rare opinion finding challenged claims eligible, offers new guidance on the boundaries of patent eligibility under 35 U.S.C. § 101. While the case centers on selectorized dumbbells—a mechanical invention—the court’s reasoning provides valuable lessons for patent practitioners, particularly those drafting claims for AI and software-based inventions.
Continue Reading PowerBlock Holdings, Inc. v. iFit, Inc.: A Rare Patent Eligibility Opinion
Quantum computing companies regularly file patent applications, but will the patents that result expire before they are commercially relevant, or could they skyrocket in value in a few years? As explained below, this is likely an excellent time to pursue patent protection for quantum technologies. Applicants should, however, present their technology carefully to get the
Patents buttress and backstop growth for medical technology (medtech) companies, period. This is especially so for early-stage ventures staking their claim in the medtech ecosystem. A strategic patent portfolio is an essential building block to have in place for a medtech company’s growth and success, especially when it comes to generating revenue or fundraising. And
This 5 Trends piece covers specialized offerings, autonomous vehicle companies, the drone industry, robotic-assisted surgeries, and intellectual property in robotics industry.
Continue Reading 5 Trends to Watch: 2024 Robotics
The search for a vaccine for the COVID-19 strain of coronavirus has put the spotlight once again on the innovative pharmaceuticals sector. As pharmaceutical companies and innovators across the globe work diligently on a vaccine, many of these companies may be looking to protect their innovation. While patents have many benefits, in the face of a global health emergency, there are some key factors innovators should consider.
Timeline for Patent Registration
Patents can provide broad protection for invention and innovation. They can also create a significant advantage in the marketplace. However, patent registration takes time and may require significant resources. According to the United States Patent and Trademark Office (USPTO), on average, it takes approximately 22 months to get patent approval. This period may be shortened by taking advantage of one of the USPTO’s accelerated examination procedures and may be shortened by utilizing the USPTO prioritized examination option, where a final decision on patentability is made within 12 months from the filing date of the patent application.
Continue Reading The Race for a COVID-19 Vaccine is On: Key Factors May Impact Patent Protection
On April 28, 2020, the United States Patent and Trademark Office (USPTO) announced a new extension of certain submissions and fees under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). This announcement supersedes the previously announced extensions of March 31, 2020, and the notice of March 16, 2020.
Read the full GT
On March 31, 2020, the United States Patent and Trademark Office (USPTO) announced extension of certain submissions and fees under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) as signed by President Trump on March 27.
If the following three steps are met, then the USPTO shall provide a 30-day extension of time.